股本结构
单位:万股
公告日期 | 2021-11-09 | 2021-11-09 | 2021-08-09 | 2021-08-09 | 2021-05-10 | 2021-05-10 |
---|---|---|---|---|---|---|
证券总股本 | 14681.27 | 14680.80 | 13678.80 | 13660.60 | 13547.04 | 13539.90 |
普通股本 | 14681.27 | 14680.80 | 13678.80 | 13660.60 | 13547.04 | 13539.90 |
优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
变动日期 | 2021-11-05 | 2021-09-30 | 2021-08-06 | 2021-06-30 | 2021-05-07 | 2021-03-31 |
注释:中概股证券总股本=普通股股本/
存托凭证比例
历史变动
公告日期 | 变动后普通股本(万股) | 变动后优先股(万股) | 变动原因 | 变动日期 |
---|---|---|---|---|
2021-11-09 | 14681.27 | 未披露 | 定期报告 | 2021-11-05 |
2021-11-09 | 14680.80 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Upon vesting of restricted stock awards
portion of settlement obligation
For exercise of stock options
|
2021-09-30 |
2021-08-09 | 13678.80 | 未披露 | 定期报告 | 2021-08-06 |
2021-08-09 | 13660.60 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of Common Stock:
In Ariix business combination
Upon vesting of restricted stock awards
For exercise of stock options
Reclassification of Redeemable Common Stock
|
2021-06-30 |
2021-05-10 | 13547.04 | 未披露 | 定期报告 | 2021-05-07 |
2021-05-10 | 13539.90 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Issuance of Common Stock:
In Ariix business combination
Private placement of Common Stock, net of issuance costs
Vesting of restricted stock awards
Exercise of stock options
Reclassification of Redeemable Common Stock
|
2021-03-31 |
2021-03-29 | 13538.74 | 未披露 | 定期报告 | 2021-03-24 |
2021-03-18 | 13538.99 | 未披露 | 定期报告 | 2021-03-15 |
2021-03-18 | 13538.99 | 未披露 | 定期报告 | 2021-03-12 |
2021-02-12 | 12052.89 | 未披露 | 定期报告 | 2021-02-09 |
2021-02-08 | 12052.05 | 未披露 | 定期报告 | 2021-02-04 |
2021-02-01 | 11986.38 | 未披露 | 定期报告 | 2021-01-28 |
2021-03-18 | 9914.60 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of Common Stock:
In ATM public offering, net of offering costs
In exchange for note receivable
For exercise of stock options
Upon vesting of restricted stock awards
Purchase and retirement of common stock
|
2020-12-31 |
2020-11-09 | 9852.14 | 未披露 | 定期报告 | 2020-11-06 |
2020-11-09 | 9849.00 | 未披露 |
更多>>
From December 31, 2019 to September 30, 2020
Issuance of Common Stock:
ATM public offering, net of offering costs
In exchange for note receivable
Exercise of stock options
Vesting of restricted stock awards
|
2020-09-30 |
2020-08-10 | 9772.01 | 未披露 | 定期报告 | 2020-08-06 |
2020-08-10 | 9844.20 | 未披露 |
更多>>
From December 31, 2019 to June 30, 2020
Issuance of Common Stock:
ATM public offering, net of offering costs
Exercise of stock options
Vesting of restricted stock awards
|
2020-06-30 |
2020-05-11 | 9259.24 | 未披露 | 定期报告 | 2020-05-07 |
2020-04-28 | 9087.25 | 未披露 | 定期报告 | 2020-04-24 |
2020-05-11 | 8724.50 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of Common Stock for:
ATM public offering, net of offering costs
Exercise of stock options
Vesting of restricted stock awards
|
2020-03-31 |
2020-03-16 | 8543.70 | 未披露 | 定期报告 | 2020-03-10 |
2020-03-16 | 8187.30 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Issuance of Common Stock:
ATM public offering, net of offering costs
Grant of restricted stock awards
Vesting of restricted stock awards
Business combination with BWR
Employee services
Acquisition of patents
Exercise of stock options
|
2019-12-31 |
2019-11-14 | 7839.40 | 未披露 | 定期报告 | 2019-11-11 |
2019-11-14 | 7827.40 | 未披露 |
更多>>
From June 30, 2019 to September 30, 2019
Issuance of Common Stock for:
Exercise of stock options
Grant of restricted stock awards
Business combination with BWR
ATM public offering, net of offering costs
Employee services
|
2019-09-30 |
2019-08-08 | 7816.60 | 未披露 | 定期报告 | 2019-08-05 |
2019-08-08 | 7762.40 | 未披露 |
更多>>
From December 31, 2018 to June 30, 2019
Issuance of Common Stock for:
Exercise of stock options
Grant of restricted stock awards
ATM public offering, net of offering costs
Employee services
|
2019-06-30 |
2019-04-16 | 7539.27 | 4.38 | 定期报告 | 2019-04-12 |
2019-04-05 | 7535.77 | 4.38 | 定期报告 | 2019-04-04 |
2019-05-09 | 7539.30 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Issuance of Common Stock for:
Exercise of stock options
Grant of restricted stock awards
|
2019-03-31 |
2019-04-01 | 7535.77 | 未披露 | 定期报告 | 2019-03-29 |
2019-04-01 | 7506.70 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of Common Stock for:
Conversion of Series B Preferred Stock
Conversion of Series B promissory notes
Public offerings, net of offering costs
Debt issuance costs
Transaction costs in business combination
Cashless exercise of stock options and warrants
Grant of restricted stock awards, net of forfeitures
Common Stock exchanged for Series C Preferred Stock
Series C Preferred Stock converted to Common Stock
Common Stock issued in business combination with Morinda
|
2018-12-31 |
2018-12-03 | 7283.59 | 未披露 | 定期报告 | 2018-11-29 |
2018-11-14 | 7283.59 | 未披露 | 定期报告 | 2018-11-14 |
2018-11-14 | 4951.41 | 0.69 | 定期报告 | 2018-09-30 |
2018-09-17 | 4939.85 | 未披露 | 定期报告 | 2018-09-10 |
2018-08-14 | 4010.92 | 未披露 | 定期报告 | 2018-08-06 |
2018-08-07 | 3993.46 | 未披露 | 定期报告 | 2018-07-30 |
2018-08-14 | 3992.58 | 未披露 | 定期报告 | 2018-06-30 |
2018-05-15 | 3920.79 | 未披露 | 定期报告 | 2018-05-08 |
2018-04-17 | 3893.36 | 未披露 | 定期报告 | 2018-04-12 |
2018-05-15 | 3664.79 | 未披露 | 定期报告 | 2018-03-31 |
2018-04-17 | 3517.14 | 16.92 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of common stock in connection with public offering
Issuance of common stock in connection with the acquisition of Maverick Brands, LLC
Issuance of common stock in connection with the acquisition of Marley Beverages, LLC
Issuance of common stock in connection with the acquisition of Premier Micronutrient Corporation
Issuance of common stock in connection with services provided
Restricted stock awards issued to employees
Recession of Series A Preferred Shares
Conversion of Series B Preferred Stock
Exercise of warrants
|
2017-12-31 |
2017-11-14 | 3461.53 | 未披露 | 定期报告 | 2017-11-13 |
2017-11-14 | 3461.03 | 未披露 | 定期报告 | 2017-09-30 |
2017-08-15 | 3433.05 | 未披露 | 定期报告 | 2017-06-30 |
2017-05-16 | 3130.71 | 53.48 | 定期报告 | 2017-03-31 |
2017-03-31 | 2770.09 | 未披露 | 定期报告 | 2017-03-24 |
2017-02-14 | 2274.73 | 49.73 |
更多>>
1.The number of shares of our common stock that will be outstanding immediately after this offering is based on 22,000,106 shares of our common stock outstanding as of February 7, 2017
|
2017-02-14 |
2017-03-31 | 2190.01 | 53.48 |
更多>>
from December 31, 2015 to September 30, 2016
Common stock issued in Xing acquisition
Stock-based compensation
Exercise of warrant
|
2016-09-30 |
From June 30, 2021 to September 30, 2021
Upon vesting of restricted stock awards
portion of settlement obligation
For exercise of stock options
From March 31, 2021 to June 30, 2021
Issuance of Common Stock:
In Ariix business combination
Upon vesting of restricted stock awards
For exercise of stock options
Reclassification of Redeemable Common Stock
From December 31, 2020 to March 31, 2021
Issuance of Common Stock:
In Ariix business combination
Private placement of Common Stock, net of issuance costs
Vesting of restricted stock awards
Exercise of stock options
Reclassification of Redeemable Common Stock
From December 31, 2019 to December 31, 2020
Issuance of Common Stock:
In ATM public offering, net of offering costs
In exchange for note receivable
For exercise of stock options
Upon vesting of restricted stock awards
Purchase and retirement of common stock
From December 31, 2019 to September 30, 2020
Issuance of Common Stock:
ATM public offering, net of offering costs
In exchange for note receivable
Exercise of stock options
Vesting of restricted stock awards
From December 31, 2019 to June 30, 2020
Issuance of Common Stock:
ATM public offering, net of offering costs
Exercise of stock options
Vesting of restricted stock awards
From December 31, 2019 to March 31, 2020
Issuance of Common Stock for:
ATM public offering, net of offering costs
Exercise of stock options
Vesting of restricted stock awards
from December 31, 2018 to December 31, 2019
Issuance of Common Stock:
ATM public offering, net of offering costs
Grant of restricted stock awards
Vesting of restricted stock awards
Business combination with BWR
Employee services
Acquisition of patents
Exercise of stock options
From June 30, 2019 to September 30, 2019
Issuance of Common Stock for:
Exercise of stock options
Grant of restricted stock awards
Business combination with BWR
ATM public offering, net of offering costs
Employee services
From December 31, 2018 to June 30, 2019
Issuance of Common Stock for:
Exercise of stock options
Grant of restricted stock awards
ATM public offering, net of offering costs
Employee services
from December 31, 2018 to March 31, 2019
Issuance of Common Stock for:
Exercise of stock options
Grant of restricted stock awards
from December 31, 2017 to December 31, 2018
Issuance of Common Stock for:
Conversion of Series B Preferred Stock
Conversion of Series B promissory notes
Public offerings, net of offering costs
Debt issuance costs
Transaction costs in business combination
Cashless exercise of stock options and warrants
Grant of restricted stock awards, net of forfeitures
Common Stock exchanged for Series C Preferred Stock
Series C Preferred Stock converted to Common Stock
Common Stock issued in business combination with Morinda
from December 31, 2016 to December 31, 2017
Issuance of common stock in connection with public offering
Issuance of common stock in connection with the acquisition of Maverick Brands, LLC
Issuance of common stock in connection with the acquisition of Marley Beverages, LLC
Issuance of common stock in connection with the acquisition of Premier Micronutrient Corporation
Issuance of common stock in connection with services provided
Restricted stock awards issued to employees
Recession of Series A Preferred Shares
Conversion of Series B Preferred Stock
Exercise of warrants
1.The number of shares of our common stock that will be outstanding immediately after this offering is based on 22,000,106 shares of our common stock outstanding as of February 7, 2017
from December 31, 2015 to September 30, 2016
Common stock issued in Xing acquisition
Stock-based compensation
Exercise of warrant